Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Cambrex will spend $9 million to expand its small-molecule active pharmaceutical ingredient (API) facility in Karlskoga, Sweden. The investment will add 28 m3 of capacity at the site, roughly a 10% increase, according to Cambrex. “This investment is in response to an increase in demand for larger-scale, multipurpose manufacturing capabilities, says Bjarne Sandberg, managing director of Cambrex Karlskoga. Cambrex recently invested $50 million in its Charles City, Iowa, API facility and said it would spend $20 million on further expansion by year-end.
This article has been sent to the following recipient: